Navigation Links
BioCryst Presents Phase I Peramivir Data at the Options for the,Control of Influenza Conference

y, 2007 BioCryst established a partnership with Shionogi & Co., to develop and commercialize peramivir in Japan. For more information about BioCryst, please visit the company's web site at http://www.biocryst.com.

Forward-looking statements

This press release contains forward-looking statements, including statements regarding future results, performance or achievements. These statements involve known and unknown risks, uncertainties and other factors which may cause our actual results, performance or achievements to be materially different from any future results, performances or achievements expressed or implied by the forward-looking statements. These statements reflect our current views with respect to future events and are based on assumptions and subject to risks and uncertainties. Given these uncertainties, you should not place undue reliance on these forward-looking statements. Some of the factors that could affect the forward-looking statements contained herein include that the favorable results of peramivir in animals may not be replicated in humans, the Phase II trial of BCX-4208 for psoriasis may not be successfully completed, that development and commercialization of Fodosine(TM) in both T-ALL and CTCL may not be successful, that we may not resolve satisfactorily the particulate matter issue with the intravenous formulation of Fodosine(TM), that we may not obtain a satisfactory SPA for Fodosine(TM) for treatment of CTCL promptly or at all, that DHHS could reduce or eliminate funding for peramivir, that we or our licensees may not be able to enroll the required number of subjects in planned clinical trials of our product candidates and that such clinical trials may not be successfully completed, that BioCryst or its licensees may not commence as expected additional human clinical trials with our product candidates, that our product candidates may not receive required regulatory clea
'"/>




Page: 1 2 3 4 5 6

Related medicine technology :

1. Inspiration Biopharmaceuticals Presents Data From Hemophilia Program at International Society On Thrombosis and Haemostasis (ISTH) Annual Meeting
2. European Society for Medical Oncology (ESMO) Presents Data from the Clinical Trial of MediGenes Cancer-Killing Virus in Press Conference
3. Cytogen Presents Phase 1 Data Showing Promising Antitumor Activity and Safety Profile of Quadramet at International Myeloma Workshop
4. SemBioSys Presents Positive Insulin Data at the American Diabetes Association Conference
5. Tranzyme Pharma Presents Initial Phase IIa Data for its Novel Ghrelin Agonist, TZP-101, in Patients with Diabetic Gastroparesis
6. Novagali Pharma Presents at AACO the Results of its Pivotal Phase III Clinical Trial of Vekacia in Children Suffering From Vernal Keratoconjunctivitis
7. BioLife Solutions Presents Data on CryoStor at International Society for Cellular Therapy Annual Meeting
8. Genaera Presents Preclinical Data on Trodusquemine (MSI-1436) for the Treatment of Obesity at the American Diabetes Association 67th Scientific Session
9. Elixir Pharmaceuticals Presents Preclinical Data Highlighting Its Ghrelin Antagonist Program at the American Diabetes Associations Annual Meeting
10. DiObex Presents Phase 2a Data of DIO-902 Demonstrating Trends of Improved Glycemic Control and Significant Reductions of LDL-Cholesterol and C-Reactive Protein
11. Solstice Neurosciences Presents Escalating Dose Study at International Congress in Istanbul, Turkey
Post Your Comments:
(Date:7/31/2014)... 31, 2014  Zacks.com announces the list of stocks featured ... analysts discuss the latest news and events impacting stocks and ... Biogen (Nasdaq: BIIB - Free Report ), Gilead (Nasdaq: ... PBYI - Free Report ), AbbVie (NYSE: ABBV - ... Report ). Today, Zacks is promoting its ,Buy, ...
(Date:7/31/2014)... and LONDON , July 31, 2014 ... and services provider for the medical industries, announced today the incorporation ... The United Kingdom has one of the ... USD 8.9 billion in 2012 and it is projected to increase ... at USD 234 billion in 2012, equal to 9.5% of GDP. ...
(Date:7/31/2014)... -- For the first time, cardiac surgeons, medical professionals ... SynCardia temporary Total Artificial Heart in a peer reviewed ... Journal of Visualized Experiments website. ... SynCardia Total Artificial Heart implantation   goo.gl/2OZyKW ... SynCardia Total Artificial Heart," a July 18, 2014 paper ...
Breaking Medicine Technology:The Zacks Analyst Blog Highlights: Biogen, Gilead, Puma Biotechnology, AbbVie and Celgene 2The Zacks Analyst Blog Highlights: Biogen, Gilead, Puma Biotechnology, AbbVie and Celgene 3The Zacks Analyst Blog Highlights: Biogen, Gilead, Puma Biotechnology, AbbVie and Celgene 4The Zacks Analyst Blog Highlights: Biogen, Gilead, Puma Biotechnology, AbbVie and Celgene 5The Zacks Analyst Blog Highlights: Biogen, Gilead, Puma Biotechnology, AbbVie and Celgene 6genae Opens Offices in London 2How to Implant the SynCardia Total Artificial Heart Detailed in Peer Reviewed Paper and Matching Video 2How to Implant the SynCardia Total Artificial Heart Detailed in Peer Reviewed Paper and Matching Video 3
(Date:7/31/2014)... INDIANAPOLIS -- A class of medications previously linked ... to negatively affect their physical functioning according to ... University Center for Aging Research, the University of ... , In a systemic review of more than ... drugs with anticholinergic properties, they report that these ...
(Date:7/31/2014)... Washington, D.C. July 31, 2014Today the Elizabeth Glaser ... announced a new partnership that will expedite the ... to health facilities in two districts of the ... partnership between EGPAF and Riders for Health will ... laboratory samples and address a critical bottleneck in ...
(Date:7/31/2014)... school researchers hope to drastically increase the number ... trials, a critical step in testing and developing ... a lack of awareness that clinical testing existsless ... in trials of experimental therapies. , As many ... still don,t enroll, according to the study,s investigators, ...
(Date:7/31/2014)... Controlled application of vacuum pressure is a promising ... (TBI), suggests an experimental study in the August issue ... the Congress of Neurological Surgeons . The journal ... a part of Wolters Kluwer Health . ... the injured area of the brainshows promise as a ...
(Date:7/31/2014)... New Delhi, India (PRWEB) July 31, 2014 ... company, has launched a new service named ‘Remove Bad ... against which bad reviews are published on various review ... study about the world of internet marketing, the sites ... by its competitors in order to tailor the service. ...
Breaking Medicine News(10 mins):Health News:Common drugs adversely impair older adults' physical as well as cognitive functioning 2Health News:Elizabeth Glaser Pediatric AIDS Foundation partners with Riders for Health in Malawi 2Health News:$1.6 million NCI grant to CWRU trains nurses to increase participation in clinical trials 2Health News:$1.6 million NCI grant to CWRU trains nurses to increase participation in clinical trials 3Health News:Vacuum treatment may limit damage after traumatic brain injury 2Health News:Reputation Management India Launches a New Service Called ‘Remove Bad Reviews’ 2
... ... defined, animal-protein free maintenance medium for human embryonic and induced pluripotent stem cells. ... Vancouver, BC (PRWEB) ... the release of TeSR™2 , a defined, animal-protein free maintenance medium for human ...
... CARMEL, Ind., Oct. 13 Conseco, Inc. (NYSE: CNO ... to ensure that all investors have equal access to information, ... 5:30 p.m. on Tuesday, October 13, 2009. The materials ... exhibits that Conseco will submit to the Securities Exchange Commission ...
... Porpoise Evans, a litigation associate in the Miami office of ... among the "40 Under 40" outstanding lawyers of Miami-Dade County ... be honored at the CFF benefit dinner on November 20, ... as one of Miami-Dade County,s top up-and-coming young lawyers is ...
... WASHINGTON, Oct. 13 America,s Health Insurance Plans (AHIP) ... today on passage of health care reform legislation in ... bipartisan health care reform that covers all Americans, improves ... affordable, sustainable path. Health plans have proposed guaranteed ...
... the following statement today from Executive Vice President ... approval today of historic health care reform legislation ... coordinated health benefits and quality focused coverage as ... chronically-ill and underserved Medicare recipients." , ...
... more pre-term infants survive, doctors see more babies with ... News) -- Increased survival of extremely pre-term infants has ... problems caused by abnormal development of blood vessels in ... looked at data on 506 extremely pre-term infants (born ...
Cached Medicine News:Health News:STEMCELL Technologies Inc. Announces Release of Defined, Animal-Protein Free Maintenance Medium for hESCs and hiPSCs 2Health News:Conseco Announces Availability of Important Information on its Website 2Health News:Cystic Fibrosis Foundation Names Greenberg Traurig Attorney D. Porpoise Evans Among the '40 Under 40' Outstanding Lawyers of Miami-Dade County 2Health News:AHIP Statement on Passage of Senate Finance Committee Legislation 2Health News:XLHealth Applauds Quality Focused Reforms in Senate Finance Committee Legislation 2Health News:Eye Problems Increasing in Preemies 2
The Columbus microplate strip washer is for individual strips or whole plates.Programming and control are via an alphanumeric display. Up to 30 methods are stored for easy recall....
... 96PW washes all 96 wells ... automatically. Separate wash and aspiration ... excellent washing ability. Pre-programmed automatic ... removable 96-channel head reduce maintenance ...
Easy to use , Allow for a flexible washing , Uniform and efficient , Very robust and reliable , Adjustable to all well shapes , Rack included (not autoclavable) , Autoclavable at 121C , No e...
... SkanWasher 300 with a ... Vacuum pressure and aspiration ... are adjustable. On-board software ... 8 different programs. External ...
Medicine Products: